VIOLA, FRANCESCO
VIOLA, FRANCESCO
Dipartimento di Scienze Cliniche e di Comunità
Drusen-specific dark adaptation profiles in intermediate age-related macular degeneration
2026 P. Forte, L. Ferro Desideri, M. Nassisi, F. Milanesi, A. Feo, I. Bagnasco, S.M. Iglesia, G. Forte, D. Scandella, F. Roccatagliata, V. Fontana, C.M. Eandi, M. Iester, J.K. Jolly, M.S. Zinkernagel, F. Viola, M. Nicolò
Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project
2026 S. Fraser-Bell, N.S. Lee, Y. Hashimoto, A. Pollreisz, A. Witmer, F. Viola, F.J. Lavid, H. Steiner, P. Gabrielle, R. Barry, R. Silva, D. Barthelmes, M.C. Gillies
Posterior segment inflammation with venous involvement following a switch to a ranibizumab biosimilar (Ximluci®): a case report
2026 S. Conte, M. Nassisi, C. Mainetti, L. Seregni, F. Viola
Standardizing Measurement of Complete Retinal Pigment Epithelial and Outer Retinal Atrophy-Classification of Atrophy Meeting Report 8
2026 D. Sarraf, F. Corvi, P.J. Rosenfeld, T. Ach, B. Blodi, F. Bottoni, M. Cozzi, U. Chakravarthy, E.Y. Chew, K. Csaky, C. Cukras, C.A. Curcio, F.L. Ferris, K.B. Freund, J. Grunwald, R.H. Guymer, F.G. Holz, G.J. Jaffe, S. Liakopoulos, T.H. Lim, J.M. Monés, C. Owsley, S. Pagliarini, D. Pauleikhoff, S. Schmitz-Valckenberg, R.F. Spaide, J. Sparrow, R. Tadayoni, A. Tufail, F. Viola, S. Fraser, G. Staurenghi, S.R. Sadda
Corneal neurotization for severe neurotrophic keratopathy: the results of a cohort of patients with a 10-year-follow-up
2025 A. Strianese, F. Biglioli, V. De Ruvo, F. Bolognesi, G. Giannaccare, F. Allevi, F. Tarabbia, F. Pozzo Giuffrida, S. Luccarelli, F. Viola, L.M. Rossetti, P. Fogagnolo
Autoimmune Retinopathy in a Patient with Common Variable Immunodeficiency
2025 C. Muzio, G. Casalino, C. Mapelli, M. Nassisi, L. Dell'Arti, A. Pece, F. Fossataro, G. Fabio, M. Carrabba, F. Viola
Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study
2025 M. Parravano, F. Viola, M. Nicolo, S. Vujosevic, L. Bianchino, E. Sicari, G. Villa, P. Lanzetta
BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints]
2025 S. Sivaprasad, A. Loewenstein, A. Carneiro, E. Midena, F. Bandello, J.H. Terheyden, J. Korobelnik, J. Zarranz-Ventura, F. Viola, M.R. Munk, N. Eter, P. Lanzetta, R. Gale, S. Vujosevic, T. Peto, F. Faraldi, J. Cunha-Vaz, R.P. Finger, A. Joussen, D. Pauleikhoff, F.G. Revel, N. Zakaria, T. Fussaro, I. De Goeij, S. Bakalash, A. Want, D. Urban, H.N. Sen, A. Berliner, C.O. Glittenberg, A. Webler-Messenger, J.L. Pluim, M. Tolentino, D. Callanan, C. Baumal, R. Safaei, R. Hasan, M.A. Memon, M. Sylvanowicz, J. Carrasco, N. Rodellar Sasot, T.F. Miller, L. Narouz-Ott, S. Specker, F. Baschiera
Ten-year incidence, risk factors and progression rate of macular atrophy in neovascular age-related macular degeneration
2025 F. Romano, M. Casaluci, A. Valastro, M. Airaldi, P. Milella, F. Pozzo Giuffrida, E. Cozzi, A. Aretti, K.Y. Teo, C.M.G. Cheung, M. Nassisi, F. Viola, G. Staurenghi, A. Invernizzi
Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study group
2025 M. Cozzi, S. Zweifel, K. Balaskas, C.A. Curcio, F. Viola, H. Mehta, J. Zarranz-Ventura, K.Y.C. Teo, L. O'Toole, J. Nolan, M. Green-Gomez, E.J. Johnson, J. Arnold, G. Staurenghi, M.C. Gillies, D. Barthelmes, A. Invernizzi
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration
2025 D. Zur, R. Guymer, J. Korobelnik, L. Wu, F. Viola, N. Eter, S. Baillif, Y. Chen, J.J. Arnold
Predictive Factors of Suboptimal Response to Topical 0.1% Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: A Real-World Retrospective Study
2025 M. Nassisi, S. Osnaghi, G. Leone, C. Mapelli, C. Altavilla, C.V. Agostoni, D.G. Ghiglioni, F. Viola
Transient Bacillary Layer Detachment During the Disease Course of Primary Vitreoretinal Lymphoma
2025 G. Casalino, A. Malerba, S. Fabris, N. Bolli, G.A. Croci, M. Pellegrini, F.G. Rossi, C. Mapelli, F. Viola
Paracentral acute middle maculopathy and hemodynamically significant patent foramen ovale
2025 C. Muzio, F. Fossataro, S. Erba, S. De Angelis, M. Mambretti, M. Pisaniello, M. Nassisi, G. Casalino, F. Viola
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
2025 E. Midena, M. Lupidi, L. Toto, G. Covello, D. Veritti, E. Pilotto, M.V. Cicinelli, R. Lattanzio, M. Figus, G. Midena, L. Danieli, E. Borrelli, M. Reibaldi, D. Tognetto, L. Inferrera, S. Donati, S. Rossi, P. Melillo, P. Lanzetta, V. Sarao, G. Gregori, C. Cagini, C.M. Eandi, A. Carnevali, V. Scorcia, E. Maggio, G. Pertile, C. Costagliola, G. Cennamo, P. Mora, R. Dell'Omo, M. Affatato, M. Passamonti, M. Parravano, N.V. Lassandro, M. Nassisi, F. Viola, N. Castellino, F. Cappellani, G. Giannaccare, F. Boscia, M.O. Grassi, D. Musetti, V. Folegani, A. Invernizzi, L. Rossetti, T. Bacci, F. Ricci, M. Lombardo, M. Romano, N. Valsecchi, M. Coppola, F. Cavarzeran, L. Frizziero
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
2024 E. Debourdeau, H. Beylerian, V. Nguyen, D. Barthelmes, M. Gillies, P.H. Gabrielle, S. Vujosevic, L. Otoole, M. Puzo, C. Creuzot-Garcher, B. Wolff, V. Daien, N. Null, A. Cohn, B. Marsh, N. Jaross, R. Barry, I. Mclean, T. Guillaumie, A. Miri, P. Gabrielle, S. Tick, A. Field, S. Wickremasinghe, C. Dayajeewa, J. Wells, A. Dunlop, S. Young, G. Mimoun, R. Guymer, P. Carnota, R. Gallego-Pinazo, A.G. Layana, M. Saenz-de-Viteri, R. Ferrier, L. Chow, H. Steiner, A. Amini, J. Chen, N. Saha, P. Windle, M. Gillies, A. Hunt, P. Beaumont, Z. Louw, A. Luckie, S. Lake, D. Qatarneh, L. Sararols, J. Suarez, P. Berdoukas, F. Viola, R.M. Milner, C. Arruabarrena, F. Ascaso, A.B. Murillo, M. Díaz, G.P. Rivases, S.A. Castiella, R. Casaroli-Marano, M. Figueras-Roca, J. Zarranz-Ventura, S.G. Moreno, A.G. Escobar, J. Gutiérrez, J. Escobar, F. Lavid, P.C. Muñoz, M.T. Sempere, F. Ricci, L.B. Iturralde, S.G. Sánchez, G. Garay-Aramburu, N.M. Sanz, P. Calvo, J. Sanchez, E.A. Alonso, M.G. Zamora, E. Ciancas, J. Gonzalez-Lopez, D. Lorenzo, M. Acebes, S. Aparicio-Sanchis, A.F. Hortelano, A.P. Sánchez, L. García García, E.S. Martínez, A.C. Gesto, M.R. Núñez, L. Manning, A. Invernizzi, L. Castelnovo, G. Michel, B. Wolff, M. Perks, J. Arnold, H. Cass, L. Otoole, K. Tang, C. Chung, V. Daien, G. Banerjee, M. Morgan, J. Game, C. Thompson, R. Chalasani, M. Chilov, A. Fung, S. Nothling, R. Chong, S. Fraser-Bell, C. Younan, D. Louis, P. Lockie, J. Wong, P. Hinchcliffe, D. Barthelmes, E.D. De Durana Santa Coloma, G. Garay-Aramburu, H.B. Morros, A. Harper, J. Oday, C. Hooper, M.J.R. Cid
Imaging-Guided Classification of Neovascularization in Neovascular Age-Related Macular Degeneration: Progress to Date
2024 G. Staurenghi, E.H. Souied, T. Iida, D.R. Chow, A. Wolf, R. Gallego-Pinazo, F. Viola, P.K. Kaiser
Short-term efficacy of photobiomodulation in early and intermediate age-related macular degeneration: the PBM4AMD study
2024 M. Nassisi, C. Mainetti, G.R. Paparella, L. Belloni Baroni, P. Milella, G. Leone, D. Galli, F. Pozzo Giuffrida, L. Dell'Arti, C. Mapelli, G. Casalino, F. Viola
Patient Experience Survey Of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
2024 N. Holekamp, B. Gentile, A. Giocanti-Aurégan, A. Garcia-Layana, T. Peto, F. Viola, P.J. Kertes, M. Mirt, A. Kotecha, J. Lambert, H.B. Lewis, G.C. Chi
One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry
2024 H. Mehta, P. Gabrielle, Y. Hashimoto, G.D. Kibret, J. Arnold, T. Guillaumie, W.J. Kheir, G. Kok, S. Vujosevic, L. O'Toole, E. Mangelschots, N. Jaross, L. Ceklic, V. Daien, F. Viola, D. Squirrell, F.J. Lavid, C. Creuzot-Garcher, D. Barthelmes, M. Gillies